Notably, in Merkel cell carcinoma, a rare neuroendocrine skin malignancy, serum G6PD activity increases significantly with cancer stage and has been established as a reliable prognostic biomarker [19]. This evidence concerns the gene G6PD and Merkel cell skin cancer.